TCM
HALO icon

Tradewinds Capital Management’s Halozyme HALO Stock Holding History

Tradewinds Capital Management’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.83K Hold
100
– – ﹤0.01% 428
2026
Q1 		$6.46K Hold
100
– – ﹤0.01% 437
2025
Q4 		$6.73K Hold
100
– – ﹤0.01% 420
2025
Q3 		$7.33K Hold
100
– – ﹤0.01% 408
2025
Q2 		$5.2K Hold
100
– – ﹤0.01% 407
2025
Q1 		$6.38K Buy
100
+70
+233% +$4.07K ﹤0.01% 401
2024
Q4 		$1.44K Buy
+30
New +$1.54K ﹤0.01% 518

Other funds holding HALO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Tradewinds Capital Management's HALO Position: Q2 2026 in Review

Tradewinds Capital Management held its Halozyme (HALO) position steady in Q2 2026 at 100 shares worth $7.83K. The position accounts for ﹤0.01% of the portfolio, ranked #428.

Tradewinds Capital Management first reported a position in HALO in Q4 2024 and has held it in 7 quarters since. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Tradewinds Capital Management held 100 shares of Halozyme worth $7.83K as of Q2 2026.
  • Tradewinds Capital Management left its Halozyme share count unchanged in Q2 2026.
  • Halozyme made up ﹤0.01% of Tradewinds Capital Management's portfolio in Q2 2026, its #428 holding.
  • Tradewinds Capital Management first reported a position in Halozyme in Q4 2024 and has held it in 7 quarters since.
  • 671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Tradewinds Capital Management's 13F filing for Q2 2026, filed 24 Jul 2026.